ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
  • Abstract Number: PB2436

    Saddle Pulmonary Embolism in the Era of Incidental Events: Incidence, Clinical Findings and Outcomes in a Single Center Cohort

    M. Aramberri1, M. Sanchez2, M. Benegas2, E. Segui2, A. García-Villa2, M. Carnevali1, C. Font2, C. Diaz-Pedroche1, 4S project

  • Abstract Number: PB2318

    Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes

    K. Wong, M. Kushnir, H. Billett

  • Abstract Number: PB0923

    Safety and Efficacy of Albutrepenonacog Alfa ih Haemophilia Patients: The Greek Experience

    M. Economou1, A. Adramerina1, E. Pergantou2, E. Nomikou3, O. Katsarou4

  • Abstract Number: OC 12.2

    Safety and Efficacy of Anticoagulant Therapy in Pediatric Catheter-related Venous Thrombosis (EINSTEIN-Jr. CVC-VTE): A Pre-specified Substudy

    K. Thom1, A.W.A. Lensing2, D. Kubitza2, A.F. Pap2, M.H. Prins3, G. Kenet4, M.P. Massicotte5, A.K. Chan6, P. Monagle7, G. Young8, C. Male1, EINSTEIN Jr CVC-VTE Investigators

  • Abstract Number: PB0960

    Safety and Efficacy of FVIII Replacement with Turoctocog Alfa in the UK

    B. Palmer1, H. Xiang1, P. Collins2, G. Dolan3, J. Hanley4, S. Shapiro5, C. Hay1

  • Abstract Number: PB1211

    Safety of Antithrombotic Therapy in Subjects with Hereditary Hemorrhagic Telangiectasia

    E. Gaetani, F. Agostini, A. Porfidia, I. Giarretta, D. Feliciani, L. Di Martino, A. Tortora, A. Gasbarrini, R. Pola

  • Abstract Number: PB2281

    Safety of Using the Wells Rule and D-Dimer Test for Excluding Acute Recurrent Ipsilateral Deep Vein Thrombosis

    L.F. van Dam1, G. Gautam2, C.E.A. Dronkers1,3, Å. Eckerbom2, W. Ghanima4,5, J. Gleditsch6, A. von Heijne2, H.M.A. Hofstee3, M.M.C. Hovens7, M.V. Huisman1, S. Kolman8, A.T.A. Mairuhu9, M. Nijkeuter10, M.A. van de Ree8, C.J. van Rooden11, R.E. Westerbeek12, J. Westerink10, E. Westerlund2, L.J.M. Kroft13, F.A. Klok1

  • Abstract Number: PB2514

    Safety of Withholding Antithrombotic Treatment in Pregnancies after Antiphospholipid Antibodies Disappearance in Women with Obstetric Antiphospholipid Syndrome, a Cohort Study

    M.M. Clavijo, C. Casali, C. Mahuad, M.D.l.A. Vicente Reparaz, M.F. Aizpurua, A. Delorenzi, A. Ventura, S. Eciolaza, M. Zerga, G. Garate

  • Abstract Number: PB0545

    Sample Stability for a Broad Panel of Coagulation Assays on the Cobas t 711 Analyser Using Plasma Stored under Different Conditions

    M. Hoffmann1, N. Gottschalk1, P. Huber2, N. von Allmen-Zürcher3

  • Abstract Number: PB1834

    Sarcoidosis and Autoimmune Thrombocytopenic Purpura: Random Association or Hematologic Manifestation of Sarcoidosis?

    Y. Cherif, M. Mrouki, S. Derbel, F. Ben Dahmen, M. Abdallah

  • Abstract Number: PB1057

    Satisfaction and Preference of Hemophilia A Patients and Parents for the Treatments in Korea; Results from a Multicentered, Cross-sectional, Observational Study

    K.Y. Yoo1, T.J. Hwang1, Y.S. Park2, Y.J. Kim3, H.R. Park3, J.S. Shin4, H.J. Lee4, C.M. Nam5, J.Y. Sun5

  • Abstract Number: PB0334

    Screening of Hematuria in Children with Hemophilia: A Preliminary Report

    D. Gurlek Gokcebay, V. Culha, V. Kose, N. Yarali, N.Y. Ozbek

  • Abstract Number: PB0924

    Screening of Inhibitor Development among Haemophilia a Patients Being Treated with Recombinant Factor VIII Concentrates in South-East Nigeria

    E. Ezigbo1, C. Nwankwo1, T. Nwagha2

  • Abstract Number: PB2337

    Seasonality in Hospitalizations for Pulmonary Embolism between 2006 – 2016

    A. Torres1, K. Quelal1, A. Tafur2, C. Torres3

  • Abstract Number: PB0958

    Second Interim Analysis Results from the STASEY Trial: A Single-Arm, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Safety and Tolerability of Emicizumab Prophylaxis in People with Hemophilia A (PwHA) with FVIII Inhibitors

    V. Jiménez-Yuste1, E. Santagostino2, R. Klamroth3, G. Castaman4, C. Shanmukhaiah5, S. Rangarajan6, J. García Chavez7, R. Martinez8, G. Kenet9, S. Robson10, C. Schmitt10, O. Meier10, M. Ozelo11

  • Abstract Number: PB0099

    Secondary Brain Damage in Mouse Models of Focal and Global Ischaemia and Haemorrhagic Stroke: A Comparative Study

    N. Lee1, C. Selan1, J. Chia1, S. Sturgeon1, D. Wright2, A. Zamani2, M. Pereira1, H. Nandurkar1,3, M. Sashindranath1

  • Abstract Number: PB1241

    Secondary Immune Thrombocytopenia in Children: Characteristics and Outcome of a Large Cohort from Two Spanish Centers

    R. Berrueco Moreno1,2,3, E. Sebastian4, M. Solsona1,2, J. González de Pablo3,4, A. Ruiz-Llobet1,2, J. Sevilla3,4,5

  • Abstract Number: PB1915

    Secondary Thromboprophylaxis in Antiphospholipid Syndrome Patients with Arterial Thrombosis: A Systematic Review and Meta-analysis

    T. Attachaipanich1, A. Aungsusiripong2, P. Piriyakhuntorn1, S. Huntrakul1, E. Rattarittamrong1, T. Rattanathammethee1, A. Tantiworawit1, L. Norrasethada1, C. Chai-Adisaksopha1

  • Abstract Number: PB0810

    Seeking New Approaches: Aberrant Clots, Fibrin Degradation Products and their Effects on Clot Stability

    C. Rea, R. Arya

  • Abstract Number: PB1465

    Selatogrel, a Potent P2Y12 Receptor Antagonist, Dissolves Pre-Formed Platelet-thrombi in vivo

    L. Crescence1, M. Kramberg2, M. Baumann3, M. Rey2, L. Panicot-Dubois1, C. Dubois1, M.A. Riederer3

  • Abstract Number: PB0032

    Selective Targeting of Shear Gradient Activated Von Willebrand Factor by the Novel Single-Chain Antibody Scfv-A1 Reduces Occlusive Thrombus Formation

    A. Rana1, T. Hoefer2, B. Niego1, S. Jagdale1,2, H.J. Albers3, E.E. Gardiner4, R.K. Andrews1, A.D. van der Meer3, C.E. Hagemeyer1,2, E. Westein1,2

  • Abstract Number: PB0809

    Self-Adjustment of Prescribed Dosing Regimens and Physical Activity by Persons with Hemophilia (PwH): Findings from the HemACTIVE Patient Survey

    D. Nugent1, A. Llinas2, K. Khair3, J. O'Hara4,5

  • Abstract Number: PB1268

    Self-Management of Oral Anticoagulation with Vitamin K Antagonist Programs Progressively Improves Time in Therapeutic Range in Pediatric Population

    R. Berrueco1,2, C. Benedicto1,2, A. Ruiz-Llobet1,2, M. Solsona1,2, M. Mesegue1,2, S. Gassiot2,3

  • Abstract Number: PB1648

    Septins Contribute to Platelet Shape and Functionality

    O. Kim1, E. Mordakhanova2, O. Vagin3, R. Litvinov1,2, J. Weisel1

  • Abstract Number: PB0237

    Sequence Mismatch Between Therapeutic (t) and Endogenous (e) Factor VIII Proteins (FVIIIs), and HLA-class-II (HLAcII)-binding in the Development of Neutralizing Anti-tFVIII-Antibodies in Hemophilia A (HA): Evidence from the PATH Study

    V.P. Diego1,2, M. Almeida1,2, K.R. Viel3, B.W. Luu1,2,4, A. Ameri5, K. Haack6, J. Curran1,2, J.S. Powell7, J. Peralta1,2, H. Mead8, R. Rajalingam9, M.A. Escobar10, L.V. Dinh4, S. Williams-Blangero1,2, C.K. Kasper11, L. Almasy12, S.A. Cole6, J. Blangero1,2, T.E. Howard2,4,13

  • Abstract Number: PB2262

    Serial Ultrasounds in Deep Vein Thrombosis Diagnosis, a Single Centre Retrospective Review

    R. Yan1, D. Manos2, D. Anderson1, S. Shivakumar1

  • Abstract Number: PB1207

    Severe Factor V Deficiency Caused by Two Novel Pathological F5 Variants – First Insights into their Effect on Factor V Function

    J. Brodard1, S. Calzavarini2, M. Pavicic3, C. Quarroz4, G. Wiedemann5, D. Baumgartner1, N. Porret1, R. Joncourt1, O. Kocher1, K. Jalowiec1, J. Rössler6, A. Angelillo-Scherrer1, J.A. Kremer Hovinga1, M. Kartal-Kaess7

  • Abstract Number: PB0505

    Severe Haemophilia A Plasma Artificially Spiked with Emicizumab and Recombinant Factor VIII Concentrates: Measurement by One-Stage and Chromogenic Factor VIII Assays

    A. Bowyer, S. Kitchen, R. Wardle, R. Maclean

  • Abstract Number: PB1477

    Severe Platelet Dysfunction in Patient with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) after Tyrosine Kinase Inhibitor (TKI) Therapy

    M.R. Cozzi1, M. Battiston2, M. Turetta1, A. Steffan1, S. Crestani3

  • Abstract Number: PB1586

    Severe Thrombocytopenia after DDAVP Test (DDAVPt) in a Girl with a p.Cys1272Gly Variant of the VWF Gen

    J.P. Frontroth, M. Hepner, A. Chaves, C. Pepe, G. Pieroni, E. Annetta, C. Cervio, G. Sciuccati

  • Abstract Number: OC 07.3

    Severity of Acute Events in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP) with or without Regular Plasma Prophylaxis: Results from the International Hereditary TTP Registry

    E. Tarasco1,2, L. Bütikofer3, G. Sinkovits4, Z. Prohászka4, A.S. von Krogh5, P.N. Knöbl6, K.D. Friedman7, J.N. George8, I. Aebi-Huber1,2, K.A. Jalowiec1, Z. Cermakova9, M. Górska-Kosicka10, J. Windyga10, I. Hrachovinova11, C.R. Largiadèr12, M. Matsumoto13, B. Lämmle1,14, J.A. Kremer Hovinga1,2

  • Abstract Number: PB0140

    Sex Bias in Animal Models of Thrombosis Research

    P.T. Tieu1,2, S. Afraz2,3, N. Dietrich1, J. Lott1, C. Slapnicar1, N. Thai4, V. Wang1, A.K.C. Chan2,5, D. Matino2

  • Abstract Number: PB1715

    SHARPIN Restrains αIIbβ3 Activation in Platelets in Three Dimensions

    A. Kasirer-Friede1, E. Peuhu2,3, J. Ivaska3,4, S. Shattil1

  • Abstract Number: PB1611

    Short-term Application of Caffeic Acid Specifically Promotes Expansion of Hematopoietic Stem Cells

    R. Wang, Y. Liu, X. Liu, Y. Liu, Y. Wang, M. Hou

  • Abstract Number: PB1153

    SIG-001 for Hemophilia A: Preclinical Safety and Efficacy Studies Conducted in Mice and Non-Human Primates

    G. Carmona, J. Huang, L. Barney, J. Sewell, K. Lai, C. Carroll, J. Schladenhauffen, M. Kapsimalis, K. Barrett, S. Drapeau, R. Vivaldi, D. Peritt

  • Abstract Number: PB0588

    Sigma Metrics Scores for Routine Haemostasis Assays in a Small Laboratory

    H.R.B. Othman

  • Abstract Number: PB1994

    Significance of Macrophage Migration Inhibitory Factor and Toll-Like Receptor 4as Predictive Factors of Sepsis in Shock Patients

    S.-H. Choi1, S.-J. Park1, K.-W. Kim2, Y.-D. Cho1

  • Abstract Number: PB1995

    Significance of Macrophage Migration Inhibitory Factor for Sepsis in Hemorrhagic Shock Patients

    S.-H. Choi1, K.-W. Kim2, S.-J. Park1, Y.-D. Cho1

  • Abstract Number: PB0087

    Silent Brain Ischemia in Thalassemia Patients: Breaking the Silence

    M. Karimi, S. Haghpanah

  • Abstract Number: PB0418

    Simulation of TF-dependent Factor X Activation on Phospholipid Vesicles: The Role and Importance of Individual Reaction Stages

    T. Kovalenko1, M. Panteleev1,2, A. Sveshnikova1,2

  • Abstract Number: PB0358

    Simvastatin Prevents Liver and Kidney Microthrombosis After Exposure to Lipopolysaccharide by Preserving the Antithrombotic Properties of the Endothelium

    V. La Mura1,2,3, N. Gagliano3, F. Arnaboldi3, P. Sartori3, P. Procacci3, E. Liguori3, N. Bitto1, G. Ristagno4, D. Dondossola5, F. Salerno3, A. Tripodi6, M. Colombo7, F. Peyvandi1,6

  • Abstract Number: PB1233

    Single Center Analysis of the Phenotype of Children Immune Thrombocytopenia with Mutation Related to Common Variable Immunodeficiency

    J. Ma, L. Fu, J. Zhang, H. Gu, H. Liu, Z. Chen, R. Wu

  • Abstract Number: PB2076

    Single Centre Daily Practice Evaluation of Bleeding and Thromboembolic Complications in Cancer Patients with Atrial Fibrillation

    G. Chu1, M.V. Huisman1, H. Gelderblom2, M.E. Hemels3,4, T. van der Hulle2, S.A. Trines5, F.A. Klok1

  • Abstract Number: PB2444

    Single Centre Experience of DOAC Use in Patients with Antiphospholipid Syndrome (APS) with Venous Thromboembolism

    K.A. Breen, A. Doyle, B.J. Hunt

  • Abstract Number: PB1184

    Single Centre Experience of Rare Bleeding Disorders

    M. Martinez, G. Sliba, P. Nally, F. Morales, G. Dolabella, F. Nally

  • Abstract Number: PB1830

    Sirolimus Is Effective in Autoimmune Lymphoproliferative Syndrome (ALPS)/ALPS-Like Syndrome: Results of a Single Centre Experience

    H. Gu, Z. Chen, J. Ma, R. Zhang, T. Wang, R. Wu

  • Abstract Number: PB0488

    Six Years of Experience with Plasma Fractionation Industries at a Private Super Speciality Hospital in South India: Renaissance in Usage of Excess Plasma in Blood Banks

    B. Bhasker, A. Aluri

  • Abstract Number: PB0808

    Small RNAs Influence the Pathophysiology of Hemophilic Synovitis and Arthropathy

    E. Sujanthi1,2, P. Sarangi1, S. Amit3, A.S. Ananthan4, C. Jamora4, P. Vemula4, G.R. Jayandharan1

  • Abstract Number: PB0121

    Small-Molecule Factor XIa Inhibitor, BMS-986177/JNJ-70033093, Prevents and Treats Arterial Thrombosis in Rabbits at Doses that Preserve Hemostasis

    P. Wong, E. Crain, A. Dilger, R. Wexler, W. Ewing, D. Gordon, J. Luettgen

  • Abstract Number: PB0022

    Smoking Status as Risk Factor and Risk Factors in Young and Elderly Patients Suffered from Myocardial Infarction

    N. Antonijevic1, D. Matic1, I. Veljic1, L. Jovanovic1, D. Mikovic2, A. Beletic3, S. Obradovic4

  • Abstract Number: PB1972

    Snake Venom Cysteine-Rich Secretory Proteins (SVCRISPS) from North American Vipers: Mechanism of Action on Blood and Lymphatic Endothelial Cells

    M. Suntravat1, O. Sanchez1, A. Reyes1, J. Bernal1, A. Cantu1, E. Salazar1, J. Galan1, W. Cromer2, D. Zawieja2, P. Davies3, E. Sanchez1

  • Abstract Number: PB1218

    Socio-Demographic Data and some Haematological Parameters of Nigerian Children Living on the Street: A Comparative Study

    P. Akpan, B. Asuquo

  • Abstract Number: PB2417

    Sodium Valproate-induced Drug Interactions with DOAC Anticoagulant Activity: A Case Report

    I. Paskaleva1, E. Doncheva1, R. Simeonova2, V. Ignatova3, A. Dramov4

  • Abstract Number: PB0430

    Soluble Glycoprotein VI is an Independent Predictor of Major Bleeding in Patients with Suspected Heparin-Induced Thrombocytopenia

    A. Pishko1, R. Andrews2,3, E. Gardiner2, D. Lefler1, A. Cuker1,4

  • Abstract Number: PB2017

    Specialized Regulatory T Cells Control Venous Blood Clot Resolution

    F. Shahneh1,2, A. Grill1, M. Klein3, T. Bopp3, K. Schäfer1,4, V.K. Raker1,2, C. Becker1,2

  • Abstract Number: PB1841

    Specific Inhibition of MRP4 Affects Several Signaling Pathways and Thrombus Formation in Human Platelets

    R. Wolf1, S. Grammbauer1, R. Palankar2, E. Moritz1, A. Greinacher2, M. Tzvetkov1, G. Jedlitschky1, B.H. Rauch1

  • Abstract Number: PB2021

    Stabilin-2 Promoter Modulates Immune Response in the Liver of Lentiviral Vector Injected Mice

    E. Borroni1, C. Borsotti1, V. Bruscaggin1, M. Talmon1, R. Famà1, B.D. Brown2, A. Follenzi1

  • Abstract Number: PB1353

    Stability of Crushed Avatrombopag Tablets Demonstrated in Multiple Food Vehicles

    R.F. Grace1,2, K. Aggarwal3, M. Vredenburg3, J.M. Despotovic4,5

  • Abstract Number: PB2039

    Standard Versus Higher Intensity Anticoagulation for Patients with Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism: A Multi-center Registry Analysis

    S. Hanigan1, X. Kong1, B. Haymart1, S. Kaatz2, G. Krol2, V. Shah2, J. Kozlowski3, J.B. Froehlich1, G.D. Barnes1

  • Abstract Number: PB0441

    Standardization of a Flow Cytometry Platelet Sialylation Assay, and reference Values for Beta-Galactose Exposure in Healthy Subjects

    D. Lasne1,2, T. Pascreau1,2, S. Darame1,2, M.-C. Bourrienne1, P. Tournoux1, A. Philippe1, S. Ziachahabi1, F. Suarez3, A. Marcais3, A. Dupont4,5, C. Denis2, A. Kauskot2, D. Borgel1,2

  • Abstract Number: PB0363

    State of the Hemostatic System in Diffuse Congenital Arteriovenous Malformations of the Extremities

    L. Chernukha1, E. Lugovskoy2, O. Kashyrova1, K. Sergey2, T. Platonova2

  • Abstract Number: PB1505

    Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene as a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)

    V. Palma-Barqueros1, J.F. Ruiz-Pividal1, J.M. Bastida2, N. Bohdan1, M.J. López-Andreo3, R. Teruel Montoya1, A. Rodriguez-Alen4, J. Padilla1, N. Revilla1, A. Marin-Quilez2, R. Benito2, J.R. Gonzalez-Porras2, V. Vicente1, M.L. Lozano1, J. Rivera1, On Behalf of the Project “Caracterización Funcional y Molecular de Trastornos Plaquetarios Congénitos”, Grupo de Trabajo de Patología Hemorrágica de la SETH

  • Abstract Number: PB2077

    Stroke, Major Bleeding, and Net-clinical Benefit of Anticoagulation in Patients with Atrial Fibrillation on Hemodialysis

    O. Königsbrügge1, S. Schmaldienst2, M. Auinger3, M. Lorenz4, R. Klauser-Braun5, J. Kletzmayr5, I. Pabinger1, M. Säemann6, C. Ay1

  • Abstract Number: PB1523

    Structural Analysis of the VWF molecule with Compound in Cis Heterozygous p.R924Q and p.A2178S Mutations Causing a Type 2B-Like von Willebrand Disease

    M. Sacco1, M. Ferrarese2, S. Lancellotti3, M. Tardugno1, M. Basso3, M. Papi4, F. Bernardi2, G. Castaman5, R. De Cristofaro1

  • Abstract Number: PB2197

    Structural Basis of the Pro-coagulant Phenotype of Prothrombin Variant Arg553Trp (p.Arg596Trp – Padua 2)

    L. Acquasaliente1, A. Covallero1, D. Peterle2, C. Bulato2, P. Simioni2, V. De Filippis1

  • Abstract Number: PB0253

    Structure-Function Relationships in Factor XII Studied with Factor XII-HGFA Chimeras

    A. Shamanaev, I. Ivanov, M.-F. Sun, D. Gailani

  • Abstract Number: PB0183

    Structures in the Presence and Absence of an Anti-Factor VIII C1 Domain Antibody Bound to a Bioengineered Factor VIII Construct Indicates Multiple C2 Domain Conformations

    J. Gish1, L. Jarvis1, S. Peters1, K. Childers1, I. Smith1, E. Parker2, J. Healey2, H.T. Spencer2, C. Doering2, P. Lollar2, P.C. Spiegel1

  • Abstract Number: PB0412

    Study of a New Synthetic Thrombin Inhibitor IEM-2280

    D. Grigorieva1, A. Sokolov2,3, E. Litasova2, E. Shamova1, I. Gorudko1

  • Abstract Number: PB0057

    Study of Fluctuations in the Endothelin Concentration of the Crew Trans-Latitude Journey Transarctica-2019

    N. Vorobyeva1, E. Melnichuk2, E. Beliakov2

  • Abstract Number: PB2209

    Study of Plasma miRNAs and Microparticle miRNAs in Severe Forms of Pulmonary Hypertension

    J. Oto1, O. Tura-Ceide2, V. Sánchez-López3, J. Osorio2, C. Bonjoch2, D. Hervás4, E. Arellano5, P. Medina1, I. Blanco2, V.I. Peinado2, R. Otero6, J.A. Barberà2, * J Oto and O Tura-Ceide have contributed equally to this work.

  • Abstract Number: PB2078

    Study of Real Clinical Practice to Evaluate the Efficacy and Safety of Edoxaban in Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation. Differences between Results by Age and Creatinine Clearance Greater than 95 ml/min

    A. Garcia Ruiz1, P. Romero Garcia2, E. Morente Constantin1, M. Jurado Chacón1

  • Abstract Number: PB0069

    Study of the Endothelial Dysfuncion in Patients with Cancer: Preliminary Results

    E. Borella, E. Campello, L. Spiezia, F. Dalla Valle, A. Poretto, G. Turatti, M. Marobin, C. Simion, P. Simioni

  • Abstract Number: PB0484

    Study of the Stability of the Main Parameters of Hemostasis Over Six Hours

    S. Hadjali-Saichi, K. Guenounou-Guemmour, I. Frigaa

  • Abstract Number: PB2504

    Study of the State of the Hemostatic System in Women with Various Pregnancy Complications

    I. Gribkova1, N. Koroleva2, A. Murashko2

  • Abstract Number: PB0058

    Study of Thrombine Generation Assay Parameters of the Crew Trans-Latitude Journey Transartika-2019

    N. Vorobyeva1, E. Melnichuk2, E. Beliakov2

  • Abstract Number: PB1014

    Subclinical deep venous thrombosis identified in 7,5% of people with hemophilia undergoing major orthopedic surgery in the absence of pharmacological thromboprophylaxis

    G. Verstraete1, C. Lambert1, F. Hammer2, C. Hermans1

  • Abstract Number: PB1227

    Successful Development and Implementation of Pharmacist-led VTE Stewardship. An Australian Tertiary Hospital Perspective

    J. Chong1,2, C. Curtain2, F. Gad3, F. Passam4, G. Soo1, R. Levy3, R. Burke5, S. Dunkley4, N. Wong-Doo6, V. Chen6

  • Abstract Number: PB1791

    Successful Improvement Sexual Dysfunction After Pelvic Irradiation by Platelet Growth Factor

    S. Mohammadi1,2, A. Samaie Nouroozi3, O. Seidi Zadeh4, M. Nikbakht1,2, M. Bagherian2, S.A. Musavi1,2

  • Abstract Number: PB1077

    Successful Inhibitor Eradication for Hemophilia A Children with Poor-risk High-titer Inhibitor Using Low-dose Immune Tolerance Induction Strategy

    Z. Li1, Z. Chen1, X. Cheng1, X. Wu1, G. Li1, Y. Zhen1, S. Cai2, M.-C. Poon3, R. Wu1

  • Abstract Number: PB0881

    Successful Multiple Surgeries in Adult Patients with Haemophilia A (HA) Treated With Turoctocog Alfa Pegol (N8-GP) in the Pathfinder 3 trial

    K. Hampton1, W.H.O. Clausen2, S. Benchikh El Fegoun3, A. Landorph2

  • Abstract Number: PB0984

    Successful Parotid Tumor Surgery in Hemophilia a Patient after Immune Tolerance Induction (ITI) with High-Purity Human FVIII/ von Willebrand Factor (vWF)

    M. Savitri, P.Z. Ramadhan, P.N. Amrita, M.N. Diansyah, U.Y. Bintoro, A. Ashariati

  • Abstract Number: PB1484

    Successful Perioperative Hemostasis for Glyoblastoma Surgery in a Patient with Glanzmann Thrombasthenia

    D. Schiavo1,2, R. Campanella3, V. Conte4, M. Capecchi1, A. Artoni1, F. Peyvandi1,5

  • Abstract Number: PB2565

    Successful Pregnancy Outcomes in Patients with Protein S Deficiency Treated with Daily Fondaparinux Regimen

    A. Permatasari1, M. Savitri2, P.Z. Ramadhan2, U.Y. Bintoro2, A. Ashariati2

  • Abstract Number: PB1573

    Successful Surgical Interventions In Children with von Willebrand Disease Type 3

    K. Papayan, N. Savenkova, E. Felker, A. Veselov, A. Gurina, E. Snezhkova, A. Bykov, A. Nesterchuk, N. Nemstsveridze, V. Avramenko, S. Yakunin

  • Abstract Number: PB0794

    Successful Treatment of a Rare Acquired Thrombin Inhibitor in a Patient with Hemodialysis-dependent End-stage Renal Disease

    C. Moonla1,2, B. Akkawat1,2, A. Sukperm1,2, M. Meesanun1,2, R. Jantasing1,2, P. Lawasut1,2, K. Takkavatakarn1, P. Cheanklin1,2, S. Krajibthong1,2, P. Watanaboonyongcharoen2,3, N. Uaprasert1,2, P. Rojnuckarin1,2

  • Abstract Number: PB1060

    Successful Use of Immunotherapy in the Management of Cancer in Patients with Hemophilia B

    D. Hedrick

  • Abstract Number: PB0186

    Suppression of Factor VIII-Specific Memory B Cells by Murine and Human BAR-Tregs

    D. Scott1, A. De Paula Pohl1, S. Venkatesha2, A. Zhang1

  • Abstract Number: PB1085

    Surgery in People with Hemophilia and Inhibitors: 10 Years of Experience in a Portuguese Comprehensive Care Centre

    C. Vaz, F. Vasconcelos, S. Fernandes, M. Reis, M. Carvalho, M. Koch

  • Abstract Number: PB0939

    Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A (PwHA) with FVIII Inhibitors: Data from the Second Interim Analysis

    G. Castaman1, E. Santagostino2, J. Kremer Hovinga3, R. Schutgens4, S. Robson5, O. Meier5, V. Jiménez-Yuste6

  • Abstract Number: PB1154

    Surgical Experience with Emicizumab: A Single Centre Experience with Central Venous Access Device Removal

    S. Badle, D. Gosrani, A. Taylor, K. Sibson, M. Mathias, R. Liesner

  • Abstract Number: PB1096

    Surgical Experience with Fidanacogene Elaparvovec

    L.A. George1, S.K. Sullivan2, K.A. High3, J.E. Murphy4, L. Smith5, J. Rupon5

  • Abstract Number: PB1104

    Surgical Management of a Hemophilia B Gene Transfer Clinical Trial Participant: A Case Report Following Etranacogene Dezaparvovec (AMT-061) Gene Therapy

    A. Giermasz1, D. Lickorish2, E. Sawyer3, R. Gut3, E. Gomez4

  • Abstract Number: PB0986

    Surrogate FVIII Activity in Patient and Constructed Plasma Samples Containing Emicizumab: A National External Quality Assurance Scheme for Blood Coagulation (UK NEQAS BC) Exercise

    A. Lowe, I. Jennings, S. Kitchen, D. Kitchen, L. Brown, S. Munroe-Peart, I. Walker

  • Abstract Number: PB2440

    Survey on the Prescription and Biological Monitoring of Direct Oral Anticoagulants in Algeria

    S. Bounaas

  • Abstract Number: PB2103

    Survival after Cancer-related Venous Thrombosis: The Scandinavian Thrombosis and Cancer Study (STAC)

    M.J.T. Crobach1,2, R.J.S. Anijs1,3, S.K. Brækken4,5, M.T. Severinsen6, J. Hammerstrøm7, H. Skille4,5, S.R. Kristensen6, B. Paulsen4,5, A. Tjønneland8, H.H. Versteeg1, K. Overvad9,10, J.-B. Hansen4,5, I.A. Næss11, S.C. Cannegieter1,3

  • Abstract Number: PB1343

    Sustained Remission after Withdrawal of Thrombopoietin Receptor-Agonists in Immune Thrombocytopenia

    J. Yamanouchi, T. Hato, Y. Ikeda, K. Takenaka

  • Abstract Number: PB1073

    Switch to Extended Half-life Recombinant Single Chain Factor VIII in Haemophilia A Patients. Experience in One Centre

    R. Jimenez-Barcenas, R.J. Nuñez-Vazquez, B. Pedrote-Amador, F.J. Rodriguez-Martorell, J.A. Perez-Simon

  • Abstract Number: PB1542

    Symptomatic Venous Aneurysm of the Internal Jugular Vein Presenting with Small Thrombotic Inclusions in von Willebrand Disease Type I

    K. Guetl1, C. Reiter2, R.H. Portugaller3, K. Tiesenhausen4, P. Gressenberger1, V. Muster1, M. Brodmann1, T. Gary1

  • Abstract Number: PB1388

    Synthesis of Antiplatelet Ortho-Carbonyl Hydroquinones: A Spiro Derivative is Selective against Collagen-Stimulated Platelets

    E. Fuentes1, D. Mendez1, F. Urra2, J.P. Millas-Vargas1, M. Alarcón1, I. Palomo1, R. Araya-Maturana1

  • Abstract Number: PB0024

    Synthetic Antisense Oligodeoxynucleotides – Loaded Microbubbles – Mediated Transfection Therapy using B-Mode Ultrasound – Guided Focused Shock Waves Decreases Neointimal Hyperplasia Restenosis after Laser Angioplasty of Advanced Atherosclerotic Severe Stenosis

    H. Mehrad1, A. Foletti2

  • Abstract Number: PB0409

    System Wide Investigation into Coagulation Profile of Premature Myocardial Infarction Subjects

    J. Dunster1, J. Wright2,3, A. Goodall2,3

  • Abstract Number: PB2471

    Systematic Review of the Risk of Bleeding in Patients with Chronic Kidney Disease Treated with Tinzaparin

    E. Colomé, M. Merino, Y. de Miguel

  • Abstract Number: PB2510

    Systematic Review of Viscoelastic Testing (TEG/ROTEM) in Obstetrics and Recommendations for Future Studies

    A. Amgalan1, T. Allen2, M. Othman3,4, H. Ahmadzia5

  • Abstract Number: PB0075

    Systemic Aspirin Esterification in Subjects with Cardiovascular Disease: Impact of Body Size

    B. Porro1, A. Di Minno2, F. Veglia1, M. Giroli1, J.P. Werba1, S. Barbieri1, S. Eligini1, S. Fiorelli1, B. Rocca3, V. Cavalca1, E. Tremoli1

  • Abstract Number: PB2519

    Systemic Evaluation of Neuroserpin, Interleukin-17 and Hemostatic Factors in Association with Clinical Parameters in Preeclamptic Women: A Principal Component Analysis Approach

    L. Oliveira Perucci1, S. Pio Gomes da Silva1, L.Â. Gonçalves de Moraes1, P. Nessralla Alpoim2, L. Carvalho Godoi2, L.M. Sant'Ana Dusse2, A. Talvani1

  • Abstract Number: PB1999

    Systemic Inflammation in Sepsis Patients Is Demonstrated by Levels of IL-8, IL-13, and TAFI

    E. Bontekoe1, D. Joshi1, M. Rondina2, E. Middleton2, A. Blair2, F. Siddiqui1, D. Hoppensteadt1, J. Fareed1

  • Abstract Number: PB1598

    Systmetic Study of Biological Properties and Functions of Bone Marrow Mesenchymal Stem Cells from Patients with Essential Thrombocythemia and Explore the Effects of Interferonα-2b on Them

    T. Sun, A. Zhang

Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley